Evidence map›Paper›PMID 27461391›Full record

ReviewNature reviews. Molecular cell biology2016

Mechanisms and regulation of endothelial VEGF receptor signalling.

Michael Simons, Emma Gordon, Lena Claesson-Welsh

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Molecular cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04855513 (Prevention of Pre-eclampsia Using Metformin), which is not on this map. Cited by 846 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
846citing papers in PubMed, 2 pooled it
58.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04855513 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

TypeinterventionalSponsorHamad Medical CorporationRan2022 to 2023Enrolled414ConditionsPreeclampsia, Preeclampsia Severe, High Risk Pregnancy, EclampsiaArmsMetformin
3 · Its place in the literature

Who cites it

846 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,446 citations in OpenAlex.

  1. Pooled it
  2. Lipedema: Progress, Challenges, and the Road Ahead.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Vascular remodeling in asthma: from mechanisms to precision medicine.Current opinion in allergy and clinical immunology · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

786 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael SimonsYale Cardiovascular Research Center, 300 George St, New Haven, Connecticut 06511, USA.
Emma GordonUppsala University, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory and Science for Life Laboratory, Dag Hammarskjöldsv 20, 751 85 Uppsala, Sweden.
Lena Claesson-WelshUppsala University, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory and Science for Life Laboratory, Dag Hammarskjöldsv 20, 751 85 Uppsala, Sweden.
Science for Life Laboratory · SEUppsala University · SE

Funding

Worldwide Cancer Research 13-1295
6 · The paper itself

Abstract

Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are uniquely required to balance the formation of new blood vessels with the maintenance and remodelling of existing ones, during development and in adult tissues. Recent advances have greatly expanded our understanding of the tight and multi-level regulation of VEGFR2 signalling, which is the primary focus of this Review. Important insights have been gained into the regulatory roles of VEGFR-interacting proteins (such as neuropilins, proteoglycans, integrins and protein tyrosine phosphatases); the dynamics of VEGFR2 endocytosis, trafficking and signalling; and the crosstalk between VEGF-induced signalling and other endothelial signalling cascades. A clear understanding of this multifaceted signalling web is key to successful therapeutic suppression or stimulation of vascular growth.

Indexed as

Signal TransductionAnimalsEndocytosisHumansNeovascularization, PhysiologicProtein TransportReceptor Cross-TalkVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factors

Identifiers

PMID27461391
OpenAlexW2486397717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.